Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42255,232,1.05 [0.88-1.27],0.575111712219748
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43718,334,0.96 [0.81-1.14],0.638477379254712
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43282,2299,0.96 [0.90-1.03],0.2344553654023618
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43756,722,1.04 [0.94-1.16],0.443415323100665
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42429,5872,0.98 [0.95-1.02],0.4421100210895754
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42619,5321,1.00 [0.96-1.04],0.9252929381165674
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43333,2023,0.95 [0.89-1.02],0.1572179910551493
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43601,149,0.98 [0.76-1.26],0.88722219337948
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40336,1588,1.02 [0.95-1.10],0.6060979490679375
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38929,1776,1.00 [0.93-1.07],0.9176912973754148
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38800,424,1.10 [0.97-1.26],0.1474158615614136
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30724,3281,0.97 [0.92-1.02],0.2381893254819722
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38543,640,0.96 [0.84-1.08],0.4855248869462445
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43691,2381,0.96 [0.90-1.02],0.2250888553145295
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Mycoses,43883,849,1.02 [0.93-1.13],0.6293143275608593
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42520,1537,0.95 [0.87-1.03],0.1777536825909025
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43774,1751,1.01 [0.95-1.09],0.6909778840476413
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41646,336,0.96 [0.81-1.13],0.6149524025670541
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43975,78,1.05 [0.76-1.45],0.7596188329822331
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43557,1534,1.02 [0.95-1.10],0.5996249092990645
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43580,128,1.04 [0.81-1.34],0.7555141468401974
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43829,265,1.09 [0.92-1.29],0.3310049921655247
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43800,236,1.08 [0.90-1.29],0.4159838667056231
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41671,688,1.09 [0.99-1.21],0.0888962573959442
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41440,457,0.87 [0.74-1.01],0.0756508880991188
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41478,168,0.90 [0.70-1.16],0.4024402213034536
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43935,91,0.84 [0.59-1.21],0.3478310045414405
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43861,257,1.01 [0.84-1.21],0.9503438918953812
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral warts,43690,86,1.20 [0.93-1.56],0.1649078670460033
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43715,111,0.90 [0.66-1.23],0.5183501925561051
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm,43477,499,0.88 [0.76-1.02],0.0902416183867027
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43826,99,0.90 [0.65-1.25],0.5429355272776293
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43785,106,0.80 [0.57-1.13],0.2014814914184357
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20167,108,0.90 [0.66-1.25],0.5388936467383713
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43400,2416,0.97 [0.91-1.04],0.380011043666509
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of meninges,43949,100,1.27 [1.01-1.59],0.0374573337235251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43865,112,1.03 [0.78-1.35],0.8447594729931498
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43931,181,1.07 [0.87-1.31],0.5486657952881202
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of ovary,23704,147,0.89 [0.68-1.16],0.3809043196490161
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43932,620,0.93 [0.82-1.06],0.2673290831179686
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Caecum,43942,505,0.94 [0.82-1.09],0.4226121371994197
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43781,118,1.14 [0.90-1.45],0.2851634326169275
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43933,369,0.95 [0.80-1.12],0.531962102672463
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Rectum,43857,604,0.96 [0.84-1.09],0.509873657977558
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43771,1054,1.02 [0.93-1.11],0.7135011122517918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43925,715,0.98 [0.87-1.09],0.6677258149397765
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Carcinoma in situ of breast,19223,122,1.00 [0.77-1.30],0.99274453639993
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19295,142,0.99 [0.78-1.27],0.9639190940427892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",35020,92,0.85 [0.59-1.22],0.379161890673663
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",35045,117,0.69 [0.48-1.00],0.0476229183883659
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43883,201,1.13 [0.94-1.35],0.2103771716704168
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Haemangioma, any site",43884,196,1.11 [0.92-1.34],0.2800266990280682
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Leiomyoma of uterus,22914,498,0.98 [0.86-1.12],0.7835933974481772
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Lung cancer and mesothelioma,30525,582,0.94 [0.82-1.07],0.3288851260867043
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Lymphoid leukaemia,35019,91,0.89 [0.63-1.27],0.5230130984424151
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35248,320,1.10 [0.94-1.28],0.2309155996415995
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35263,335,1.04 [0.89-1.22],0.6140369719678594
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19422,163,1.11 [0.90-1.37],0.3381713677827873
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",35066,138,1.03 [0.81-1.32],0.7948061981190246
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",35104,176,0.91 [0.72-1.17],0.4716874902693234
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",35099,171,0.98 [0.77-1.23],0.8421582302272308
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19389,130,1.31 [1.09-1.58],0.004152545401027
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",35088,160,0.98 [0.78-1.25],0.9000714450176213
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16839,1170,1.01 [0.93-1.11],0.775614193462492
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35125,197,0.87 [0.68-1.10],0.2448460003154992
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",35060,132,1.03 [0.80-1.33],0.8272122676259117
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,35099,171,0.98 [0.77-1.24],0.8487317267582491
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanocytic naevi,43643,351,1.11 [0.97-1.28],0.138847408395052
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanocytic naevi of trunk,43911,154,0.92 [0.71-1.19],0.5367213038550469
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanoma in situ,34984,139,0.99 [0.76-1.28],0.9097277003416282
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",35085,157,0.78 [0.58-1.04],0.0938940375090331
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35197,269,0.90 [0.73-1.10],0.2903733733441362
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35329,401,0.86 [0.72-1.02],0.0762227604561144
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",35092,164,1.02 [0.81-1.28],0.8960082560061957
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Other benign neoplasms of skin,43668,276,1.13 [0.96-1.32],0.1397036160257837
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36732,1804,0.99 [0.92-1.06],0.7670315706097096
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36828,1900,1.00 [0.93-1.07],0.9240697683939874
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43461,591,1.02 [0.91-1.15],0.7335349319306468
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40829,151,0.93 [0.71-1.20],0.5711713335993838
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42998,128,1.02 [0.79-1.32],0.8814459716893158
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42656,4839,1.01 [0.97-1.06],0.5873924375211123
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41549,79,0.86 [0.59-1.27],0.4567482761022526
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43274,87,0.86 [0.60-1.24],0.4249581355730069
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43179,2501,1.07 [1.01-1.13],0.0207033281798125
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43177,2499,1.07 [1.01-1.13],0.0228449756966283
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40824,146,1.04 [0.81-1.32],0.7783049903975653
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43429,1959,1.08 [1.02-1.15],0.0145203482984086
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43380,193,0.87 [0.68-1.11],0.2662949562627615
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42979,109,0.79 [0.56-1.12],0.1823756448869714
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42980,110,0.97 [0.72-1.30],0.8256043705677355
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43648,461,1.03 [0.90-1.18],0.7078227237306638
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43802,93,1.03 [0.76-1.38],0.869479631456584
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43569,382,0.97 [0.83-1.14],0.7464152002086596
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41645,175,1.03 [0.83-1.29],0.7659024752932109
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34144,506,0.98 [0.85-1.12],0.7556022838220453
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40995,193,0.85 [0.66-1.09],0.1998366237651892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,41022,220,0.87 [0.69-1.10],0.242723143195038
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33733,95,1.27 [1.01-1.60],0.0406906544698867
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40858,107,0.82 [0.58-1.15],0.2566886632928273
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39944,387,1.00 [0.86-1.16],0.999034449930324
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43208,899,1.05 [0.95-1.15],0.3232380750151263
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42769,460,0.95 [0.82-1.10],0.5056103733438095
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42483,174,1.17 [0.97-1.42],0.1072268750115741
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43392,2641,1.02 [0.96-1.08],0.6034910220657248
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38402,2571,1.01 [0.95-1.07],0.688806039235245
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33741,103,0.79 [0.55-1.13],0.1949230825722134
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40636,138,1.09 [0.86-1.37],0.4859657126005063
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34104,466,1.06 [0.93-1.21],0.3445638211028879
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33737,99,0.98 [0.71-1.33],0.8768442412491295
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39590,5952,1.02 [0.98-1.06],0.3960270374519479
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33975,337,1.05 [0.90-1.23],0.560668178395216
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34571,933,1.04 [0.95-1.14],0.4177471143971496
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43841,536,1.06 [0.94-1.20],0.311369916083144
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43523,218,1.07 [0.89-1.30],0.4709152836153181
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33852,214,1.09 [0.90-1.31],0.3831800817411174
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33742,104,1.25 [1.00-1.57],0.0453539090833068
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,43070,2572,1.01 [0.95-1.07],0.8270979127277398
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,34065,427,1.03 [0.90-1.19],0.6571907253163692
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34099,461,1.04 [0.91-1.19],0.5566130656406392
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34699,1061,1.06 [0.97-1.16],0.1934509737464637
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33820,182,1.10 [0.90-1.34],0.3403134553141877
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43511,206,1.02 [0.83-1.25],0.8405302208423842
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34651,1013,1.09 [1.00-1.19],0.0500706464617018
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34453,815,1.10 [1.00-1.21],0.0598022605817164
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39668,111,1.08 [0.83-1.40],0.5828995483215954
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42050,8412,1.02 [0.99-1.05],0.2624980148823234
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40573,75,0.93 [0.65-1.34],0.7029854907213475
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40596,98,0.87 [0.62-1.21],0.413012140378531
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43667,3257,1.02 [0.97-1.08],0.4285734192627821
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43667,3251,1.02 [0.97-1.08],0.439055787274109
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40583,85,0.90 [0.63-1.28],0.5631791800152419
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43392,2048,1.02 [0.95-1.09],0.59455568142258
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36271,2633,1.07 [1.01-1.13],0.0201028361473022
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43956,352,1.03 [0.88-1.20],0.726479703550214
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42437,128,0.95 [0.72-1.26],0.7319356976962146
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41524,180,0.85 [0.66-1.09],0.1998434990440289
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41585,241,1.10 [0.93-1.31],0.2746298782589649
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33911,273,1.05 [0.89-1.25],0.5507755095018724
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40040,265,1.08 [0.91-1.28],0.3656313599235883
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3618,140,1.00 [0.77-1.30],0.9875882250771348
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3845,412,1.17 [1.03-1.33],0.0151208602561678
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39882,107,1.27 [1.02-1.60],0.0349011271683714
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3559,82,0.96 [0.67-1.37],0.8154547390281185
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42925,3150,1.04 [0.98-1.09],0.1740452836100615
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42874,565,1.02 [0.90-1.16],0.7484190989695967
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40171,614,1.01 [0.90-1.14],0.8766936765989619
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34885,1247,1.01 [0.92-1.09],0.882749721489233
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43780,410,0.83 [0.70-0.99],0.0339417120511458
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),42069,270,1.04 [0.88-1.24],0.6341550014748817
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Angina pectoris,40232,2000,0.97 [0.90-1.04],0.3326459317192707
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,42203,404,1.09 [0.95-1.24],0.2095214802284236
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41897,98,1.05 [0.80-1.39],0.7143375798961407
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",42129,330,0.98 [0.82-1.15],0.7726665013054844
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27263,3173,0.96 [0.91-1.01],0.1298938039792257
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,AV-block,37147,714,0.96 [0.85-1.08],0.4553111529767918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43873,697,0.97 [0.86-1.09],0.5951534223767033
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24408,318,1.07 [0.92-1.25],0.4040372116893378
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36723,290,0.97 [0.81-1.17],0.7745095692320807
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36595,162,0.98 [0.77-1.25],0.8669547319300512
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43971,76,1.05 [0.75-1.45],0.7867297476978918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Conduction disorders,38185,1752,0.96 [0.89-1.03],0.2471397058076149
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41694,3494,1.00 [0.95-1.05],0.9735417967878456
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38498,12927,1.00 [0.97-1.02],0.8004876209552012
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41645,443,0.83 [0.70-0.98],0.0272726755490428
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Endocarditis,36552,119,0.98 [0.74-1.30],0.8989385672308571
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43622,1828,1.02 [0.96-1.10],0.5026682322039049
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypertension,40049,11060,1.01 [0.98-1.04],0.6085472878737257
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",40062,11073,1.01 [0.98-1.04],0.6165008779768046
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43675,132,1.24 [1.01-1.52],0.0408820039522665
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29310,321,1.14 [0.99-1.33],0.0732330424656279
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29157,168,1.09 [0.87-1.36],0.4468210055661404
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypotension,43735,1920,0.99 [0.93-1.07],0.8731429358981605
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42428,182,0.71 [0.53-0.94],0.0168630331665331
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41998,3766,0.98 [0.93-1.03],0.4530741154163223
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43361,955,0.98 [0.88-1.08],0.6423399226191937
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,37042,609,1.01 [0.90-1.14],0.8582476213345841
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43197,1415,0.97 [0.89-1.05],0.3988081158872755
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39424,1192,0.98 [0.89-1.07],0.6143425408651157
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43815,265,0.85 [0.68-1.05],0.1210450283111479
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43923,518,0.91 [0.79-1.05],0.2211512409100729
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,41288,86,1.10 [0.82-1.48],0.5261692981048756
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other aneurysm,41927,128,0.85 [0.62-1.15],0.2824513221638159
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,37157,724,1.04 [0.94-1.16],0.4478335121394248
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41970,171,1.11 [0.90-1.36],0.326478269240157
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42197,398,1.09 [0.95-1.25],0.2361396781808918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36735,302,0.86 [0.71-1.05],0.140669491366454
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,41351,149,0.98 [0.76-1.26],0.8533662878333578
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41282,80,1.07 [0.79-1.46],0.6469116363998062
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41578,103,1.18 [0.92-1.51],0.1817235859197759
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41421,219,0.89 [0.71-1.12],0.3341276792314951
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,38145,1712,1.01 [0.94-1.09],0.7204510986154311
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41906,91,0.83 [0.58-1.20],0.3328046534398013
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42713,914,1.07 [0.98-1.18],0.1315262530090043
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42927,604,1.10 [0.98-1.23],0.1011565970791486
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42491,1016,1.03 [0.94-1.13],0.5362210647047875
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24648,558,1.10 [0.99-1.23],0.0889058312728618
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42420,675,1.05 [0.94-1.17],0.3869118545419555
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41776,574,0.84 [0.73-0.97],0.0193662833827036
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43122,799,1.01 [0.91-1.12],0.8843986503212148
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43848,1090,1.05 [0.96-1.14],0.3139803179769679
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,37010,577,0.96 [0.84-1.09],0.511844615679037
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42919,596,1.10 [0.99-1.23],0.0885026484137767
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41794,319,0.92 [0.77-1.10],0.3640644965078159
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43338,1092,0.95 [0.87-1.05],0.3238654069750049
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43302,1156,0.95 [0.87-1.04],0.2983226991393936
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42380,100,0.85 [0.60-1.19],0.339986366859405
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41931,133,1.12 [0.89-1.41],0.3322239693139429
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42784,378,1.10 [0.96-1.26],0.1850956513944077
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42217,435,0.88 [0.74-1.03],0.1055744642127076
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Varicose veins,41904,702,0.97 [0.87-1.09],0.6519439291718192
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41825,145,1.04 [0.82-1.32],0.7552508965500755
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43587,1249,0.95 [0.87-1.04],0.3071531757709724
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43764,619,0.91 [0.79-1.03],0.1418912051638769
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38522,2415,1.03 [0.97-1.09],0.3601526962051521
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Any mental disorder,42873,6766,1.00 [0.96-1.04],0.9163754912281477
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43686,722,0.88 [0.77-0.99],0.0389341302299396
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38798,2691,1.01 [0.95-1.07],0.8265481398072339
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36245,138,0.90 [0.68-1.18],0.4418752456478548
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Smoking dependency,43058,2331,0.99 [0.93-1.06],0.8593171269417117
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38882,2775,0.97 [0.91-1.03],0.2648053636513129
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Vascular dementia,43165,213,0.93 [0.75-1.17],0.5466920605531792
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Alzheimer disease,43973,571,0.96 [0.84-1.10],0.5677420433663091
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29800,101,0.85 [0.61-1.20],0.3543095040642892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Bell's palsy,40962,138,1.12 [0.89-1.40],0.3256353161767636
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41666,842,0.95 [0.86-1.06],0.3940534208091806
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Cerebral cysts,43285,379,0.97 [0.83-1.14],0.6989161132618984
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43836,524,0.85 [0.73-0.99],0.0349387731712427
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,43140,92,1.22 [0.95-1.56],0.1178212890008864
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43947,112,0.83 [0.60-1.16],0.2810916307231916
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",43022,116,1.03 [0.78-1.35],0.8334611200083015
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Epilepsy,41373,483,1.06 [0.93-1.20],0.3934937486516751
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43165,2275,1.00 [0.94-1.07],0.9043392316893664
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43899,704,0.94 [0.83-1.06],0.3037745569949953
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42967,4289,1.00 [0.96-1.05],0.9951292415156576
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,43333,91,1.10 [0.83-1.46],0.4889788502223596
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Hemiplegia,43724,412,0.83 [0.70-0.98],0.0322440182935852
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Hydrocephalus,43010,104,0.83 [0.59-1.16],0.2742855611430478
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43942,118,0.79 [0.57-1.10],0.1594337128438145
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40957,133,1.07 [0.84-1.35],0.5881541265048371
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40957,133,0.90 [0.67-1.19],0.4540326002220778
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Memory loss,42920,197,0.99 [0.79-1.23],0.9102461243951412
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Migraine,41491,601,0.95 [0.84-1.08],0.4566280490302516
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43857,545,0.95 [0.83-1.09],0.4751903118470795
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Motor neuron disease,29992,255,0.97 [0.80-1.18],0.7571455609974238
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43676,184,0.97 [0.78-1.21],0.7947985641679591
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42843,2019,1.00 [0.94-1.07],0.9007372242430784
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Neurological diseases,41450,6181,0.99 [0.95-1.02],0.4480464521289522
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43360,312,0.99 [0.83-1.18],0.9061106266010936
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41501,677,0.96 [0.85-1.08],0.5081584723989945
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43843,487,0.88 [0.76-1.03],0.108907630972702
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35180,1090,1.00 [0.92-1.10],0.9341808049777892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,43027,121,1.09 [0.85-1.40],0.4938762394613255
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,43142,236,0.78 [0.61-0.98],0.0365782712599557
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43447,252,0.94 [0.77-1.15],0.5284352489642873
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40987,163,1.12 [0.91-1.38],0.2879252327615371
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other headache syndromes,40990,100,0.92 [0.67-1.26],0.596951802270408
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other neurological diseases,43773,867,0.96 [0.87-1.07],0.474899620279625
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other sleep disorders,41818,928,0.97 [0.87-1.07],0.5279157293816388
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Parkinson's disease,43931,414,0.95 [0.81-1.11],0.5183191220293681
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,43002,96,1.10 [0.84-1.45],0.4728974782969481
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43971,114,0.89 [0.65-1.22],0.4750001431605659
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Sleep apnoea,43576,809,0.97 [0.87-1.08],0.5363828204191998
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43438,82,0.92 [0.64-1.32],0.6414854786847868
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43946,299,0.98 [0.82-1.17],0.7848762521620344
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40911,87,1.15 [0.87-1.51],0.330700799574917
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43973,577,0.97 [0.85-1.10],0.6520075796804876
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),43099,206,0.91 [0.72-1.14],0.4052968751109705
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,43012,162,0.82 [0.62-1.09],0.1673054769427404
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43285,674,1.04 [0.93-1.16],0.5062750382246626
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43694,384,1.13 [0.99-1.30],0.0642431904296059
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42265,89,1.29 [1.02-1.63],0.0343933858300949
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42279,103,1.17 [0.92-1.50],0.2007008708652952
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43790,92,0.89 [0.63-1.26],0.5038149950461646
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43536,250,1.03 [0.86-1.24],0.714152269206191
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3566,88,0.91 [0.63-1.29],0.5871702388320625
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4304,163,1.01 [0.79-1.28],0.9487696517477434
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,43014,164,1.02 [0.81-1.28],0.8681368880588274
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43629,1750,1.02 [0.95-1.10],0.55576568421094
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43342,1166,1.12 [1.04-1.21],0.0031440560343543
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42547,371,1.18 [1.04-1.35],0.0090695999123989
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43834,1223,0.99 [0.90-1.07],0.7377598641969949
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43959,115,0.98 [0.74-1.30],0.8827117525880791
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43712,1101,1.00 [0.91-1.09],0.9595823213774146
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43902,616,1.06 [0.94-1.18],0.356151992208933
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43811,309,1.09 [0.93-1.27],0.2992013914969385
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42279,103,1.25 [0.99-1.57],0.0565003348095652
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42292,116,1.29 [1.05-1.58],0.0145922129498451
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42267,91,0.89 [0.63-1.26],0.5207231148011642
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43816,1189,0.99 [0.90-1.08],0.7612556857781991
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42938,311,0.99 [0.84-1.18],0.9204961779677204
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42692,81,0.84 [0.57-1.23],0.3631832898088224
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43456,170,0.90 [0.70-1.16],0.4017095312230543
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43746,460,1.11 [0.98-1.25],0.1082338524283822
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42935,324,0.96 [0.81-1.15],0.6837850619901276
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43688,186,1.06 [0.86-1.30],0.5823780138265152
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43401,774,0.99 [0.89-1.10],0.8761333604791053
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,43082,232,0.96 [0.78-1.17],0.6770177820124457
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41271,3711,1.03 [0.98-1.08],0.2827769351234659
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43690,404,1.12 [0.98-1.28],0.0881995253564796
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43936,260,1.11 [0.94-1.31],0.2179257051508892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42868,692,1.11 [1.01-1.23],0.036978702396674
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43401,115,0.83 [0.60-1.15],0.262508305567331
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43937,93,0.90 [0.64-1.27],0.5421148441036476
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42320,144,1.12 [0.89-1.39],0.3343273607192497
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42431,255,1.00 [0.83-1.20],0.9733441263502932
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,42076,197,1.16 [0.97-1.39],0.1059658325931911
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42708,97,0.82 [0.57-1.17],0.2646103588204768
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41991,112,0.93 [0.69-1.26],0.6411375564425836
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42773,146,0.98 [0.77-1.26],0.8967631392566773
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42951,324,1.06 [0.90-1.23],0.5011363434317256
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42380,204,1.18 [0.99-1.40],0.0646366954254306
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,42067,188,1.13 [0.93-1.37],0.206725152231201
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,42013,134,1.05 [0.82-1.35],0.6880431930646633
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40592,3032,1.00 [0.95-1.06],0.9874988052898316
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42297,121,1.09 [0.85-1.40],0.4849123263615661
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43542,692,0.98 [0.87-1.10],0.7370364862949184
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42949,99,1.15 [0.89-1.48],0.2950616644329384
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),43124,274,1.08 [0.91-1.27],0.3929829087544523
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43593,153,0.96 [0.74-1.23],0.7317642257038006
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43900,197,1.07 [0.88-1.31],0.5095522000705665
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43753,219,1.04 [0.85-1.26],0.7149837158387379
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43550,110,1.19 [0.95-1.51],0.1315378708201318
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,43551,111,1.17 [0.92-1.49],0.1900184670239007
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43795,1489,1.05 [0.97-1.13],0.2075885820726854
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43371,1065,1.09 [1.00-1.18],0.0484318187360044
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42519,213,0.88 [0.70-1.11],0.2733173424871236
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42446,140,0.91 [0.69-1.20],0.5006645584690135
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,43551,120,0.88 [0.65-1.20],0.4260934679279715
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43794,363,0.83 [0.69-0.99],0.0414638494437521
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43537,106,0.91 [0.66-1.25],0.5555359609153518
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,All influenza,40605,197,1.10 [0.91-1.33],0.3373910163456853
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40601,193,1.10 [0.90-1.34],0.3458758175441853
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30147,204,0.96 [0.78-1.19],0.7350078526370185
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43763,485,0.96 [0.83-1.10],0.5621994364946752
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32534,3041,1.02 [0.97-1.07],0.4999912950306677
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32937,2994,1.02 [0.97-1.08],0.4286013227427264
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43285,236,1.11 [0.93-1.32],0.2597628492439217
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40544,136,1.07 [0.84-1.36],0.6100621213426582
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Bronchiectasis,38069,589,0.98 [0.87-1.12],0.809428723309868
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37576,96,0.99 [0.73-1.35],0.9540439904049411
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42243,4763,0.99 [0.95-1.04],0.7328300407734949
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41617,128,0.80 [0.58-1.10],0.1664852759305021
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41747,258,1.01 [0.84-1.21],0.9135438888349026
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43635,1999,0.94 [0.88-1.01],0.1029973337635463
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41679,190,1.01 [0.82-1.26],0.90545129282265
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40427,8899,1.00 [0.97-1.03],0.9130803326774918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42122,633,1.00 [0.89-1.13],0.9972651663075244
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Early onset COPD,42187,551,0.92 [0.80-1.06],0.2399768238416711
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Emphysema,38015,535,0.99 [0.87-1.13],0.8993816945442669
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41708,506,0.97 [0.85-1.12],0.7048099356063168
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43590,3182,0.98 [0.93-1.04],0.564417750288835
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41765,563,0.98 [0.86-1.11],0.7093803157512554
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Later onset COPD,42236,1448,0.95 [0.88-1.03],0.2406106308840588
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43949,520,0.88 [0.76-1.02],0.0925716089269938
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Nasal polyp,41677,188,1.03 [0.83-1.27],0.7859284884203029
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43541,1623,0.99 [0.92-1.07],0.8083594650385988
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,43566,3366,1.03 [0.98-1.08],0.2929064708587386
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42926,1437,1.01 [0.93-1.09],0.8537050256167067
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other pleural conditions,40286,86,0.88 [0.61-1.27],0.5029631300205539
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43805,695,1.00 [0.89-1.12],0.939597976110176
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43785,2197,1.03 [0.97-1.10],0.3086305682946461
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pleural effusion,41859,1659,1.06 [0.99-1.13],0.1095181524536979
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pleural plaque,40473,273,0.92 [0.75-1.12],0.3803792874003634
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",43164,2756,1.01 [0.95-1.07],0.8069352056230917
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43835,406,0.87 [0.73-1.03],0.0997760432944812
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pneumothorax,40408,208,1.01 [0.82-1.24],0.9407865506574428
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pollen allergy,43934,413,0.98 [0.85-1.14],0.8034915090255712
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,43220,110,1.07 [0.82-1.40],0.6036380000162391
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,30034,91,1.03 [0.77-1.38],0.8522355159414252
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43505,1587,0.99 [0.92-1.07],0.7964479352412251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41975,486,0.96 [0.83-1.10],0.5479640280541276
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Viral pneumonia,40816,408,0.92 [0.79-1.08],0.3286122177165612
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43311,336,0.87 [0.73-1.05],0.1517766454115834
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20308,188,0.94 [0.75-1.18],0.5891394770255183
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31150,108,0.91 [0.67-1.24],0.5570098851147784
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute appendicitis,43690,242,0.97 [0.79-1.18],0.7395322803966862
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute gastritis,33157,144,1.11 [0.89-1.38],0.3697267551751735
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40856,320,0.91 [0.76-1.09],0.2977131628117361
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute peritonitis,43158,153,1.04 [0.82-1.31],0.7380600854049236
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42463,126,0.97 [0.73-1.28],0.8164734986565719
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33743,730,0.95 [0.85-1.07],0.4256552726986929
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40704,168,1.03 [0.83-1.29],0.7678482818752401
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43259,168,1.03 [0.83-1.29],0.7745426939906119
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Cholecystitis,40868,332,0.91 [0.76-1.09],0.2867265641542271
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Cholelithiasis,42255,1719,1.02 [0.95-1.09],0.6269121104905098
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Chronic gastritis,33526,513,1.10 [0.98-1.24],0.1187137772819132
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40620,84,0.63 [0.40-0.97],0.0366279722965645
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43721,178,1.06 [0.85-1.31],0.6042713171630967
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Coeliac disease,41264,194,1.35 [1.16-1.56],8.682127717473438e-05
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Collagenous colitis,41112,131,0.78 [0.57-1.07],0.1263586677556827
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43706,326,1.02 [0.87-1.20],0.7865369074766347
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Constipation,43541,2777,0.98 [0.92-1.04],0.4350023670343848
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Crohn disease,41133,152,0.88 [0.67-1.16],0.3722060104492195
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43366,110,0.90 [0.65-1.23],0.5008822608650935
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41123,142,0.95 [0.73-1.24],0.7052414950704189
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Dental caries,42705,390,0.88 [0.74-1.04],0.1261541787785526
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39487,3726,1.00 [0.96-1.05],0.8604039843585263
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43755,307,0.96 [0.80-1.14],0.6235468129892909
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of liver,43766,1429,1.05 [0.97-1.13],0.2057771904598561
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40284,7271,1.01 [0.98-1.05],0.4568731086403106
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43256,941,1.02 [0.93-1.12],0.7041756632171883
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43823,818,1.04 [0.94-1.15],0.397155226800514
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42510,195,1.01 [0.82-1.25],0.9120459264103624
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42262,106,0.73 [0.51-1.05],0.0937507775453399
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43457,2387,1.05 [0.99-1.12],0.0846162670066493
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of tongue,42277,188,1.11 [0.92-1.35],0.28181968374875
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42938,2402,1.00 [0.94-1.07],0.9192114490464272
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36401,5359,0.98 [0.94-1.02],0.2823795761824077
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,33348,335,1.12 [0.97-1.30],0.1078999356661272
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43821,266,1.15 [0.98-1.35],0.0818134468635458
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43829,90,1.14 [0.88-1.49],0.3293474515547914
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42552,215,1.04 [0.85-1.27],0.6805328001407296
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31294,252,0.96 [0.79-1.16],0.6497947020422028
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33949,936,0.99 [0.90-1.09],0.8286921245636012
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastric ulcer,33626,613,0.95 [0.84-1.08],0.4569562927100771
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37232,4219,0.98 [0.93-1.02],0.3439750327203815
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33926,913,1.02 [0.93-1.13],0.6167998253456906
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34067,14020,1.00 [0.97-1.02],0.8100249989490957
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,GI-bleeding,43020,1950,1.01 [0.94-1.08],0.7750385147277004
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42422,107,1.09 [0.84-1.42],0.5334233093324466
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32676,2111,1.00 [0.94-1.07],0.983159468014629
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42440,103,1.28 [1.03-1.60],0.0253735847116407
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Hernia,41205,5444,1.01 [0.97-1.05],0.6581824210253814
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Impacted teeth,43840,84,1.20 [0.92-1.55],0.172683516821901
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Impaction of intestines,31141,99,1.06 [0.80-1.40],0.7012384947260335
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Inguinal hernia,37287,1526,1.01 [0.94-1.09],0.7244469374140082
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35934,173,1.09 [0.89-1.34],0.4201044770295644
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31203,161,0.94 [0.74-1.21],0.6438665509504635
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41302,232,1.27 [1.09-1.47],0.0016095828981959
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31980,938,0.93 [0.84-1.03],0.1537110830667107
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43926,615,1.09 [0.98-1.22],0.1098050144141417
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42248,1267,1.01 [0.93-1.10],0.7315816070145296
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42672,1691,1.02 [0.95-1.09],0.6052898792541899
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33327,314,0.93 [0.77-1.11],0.4260119335996223
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oesophagitis,34045,1032,0.96 [0.88-1.06],0.4579004135194197
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43884,234,1.01 [0.83-1.22],0.933624540275559
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35875,114,1.11 [0.87-1.43],0.3989868055589456
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33332,2290,0.97 [0.91-1.03],0.3077521254528642
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41000,464,1.02 [0.89-1.17],0.8109701135667985
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40803,267,0.96 [0.80-1.16],0.6966687047310578
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,34021,2979,0.96 [0.90-1.01],0.1206661364847516
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40559,9517,0.97 [0.94-1.00],0.0631476543931891
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42250,353,1.10 [0.95-1.27],0.1902719331094544
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of liver,43502,1165,1.07 [0.99-1.16],0.0898411504550875
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34129,1116,0.98 [0.89-1.07],0.6430432838297597
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40786,250,0.88 [0.71-1.09],0.2359502795607475
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43711,706,1.04 [0.93-1.16],0.4959446952832955
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34608,1595,0.99 [0.91-1.07],0.7375374289234493
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,43045,1975,1.01 [0.95-1.08],0.728282758888035
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42614,299,1.01 [0.85-1.20],0.8906182298197585
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33900,2858,0.96 [0.91-1.02],0.2068300280370787
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36410,3397,1.02 [0.97-1.07],0.4381454078857735
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42505,168,1.04 [0.83-1.30],0.7579048798663611
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42461,1480,1.01 [0.94-1.10],0.719974783803106
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31629,587,1.12 [1.00-1.25],0.0489489431738129
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43810,107,1.12 [0.88-1.44],0.3517186613660991
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31876,834,1.12 [1.02-1.23],0.0162670231855241
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41331,261,1.15 [0.97-1.35],0.0993665886061845
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43951,99,1.17 [0.91-1.50],0.2286725900750363
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42323,201,1.07 [0.88-1.30],0.470202569536589
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Toxic colitis,41076,95,1.03 [0.77-1.40],0.8229627462556529
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33481,468,1.09 [0.96-1.24],0.1645977539044252
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,41255,274,1.02 [0.86-1.22],0.810860662322015
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41211,230,0.92 [0.74-1.14],0.4419792726403746
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Umbilical hernia,36217,456,1.02 [0.89-1.17],0.81592142364038
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31343,301,1.03 [0.87-1.22],0.741766600580238
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ventral hernia,36197,436,1.14 [1.00-1.29],0.043494494844573
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Volvulus,31175,133,1.20 [0.97-1.48],0.0883485429104216
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43844,485,0.86 [0.74-1.01],0.057858170373962
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43432,137,0.66 [0.47-0.93],0.016991942337155
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40552,271,0.86 [0.70-1.06],0.1591742109683658
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42874,1185,0.89 [0.81-0.98],0.0197021401216463
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41991,302,1.08 [0.92-1.26],0.3693500186715512
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40932,651,0.91 [0.80-1.04],0.1589617760141423
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43451,464,1.14 [1.01-1.28],0.0377812167172751
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43791,804,1.07 [0.97-1.18],0.1524691103078568
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,43070,83,1.02 [0.74-1.41],0.8896566648015464
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41336,5404,0.95 [0.91-0.99],0.0144136077186228
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43195,747,0.99 [0.89-1.11],0.8978344319775424
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42966,518,0.98 [0.86-1.12],0.7376917736202282
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43298,1609,0.96 [0.89-1.04],0.3651486162090834
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43945,90,0.75 [0.51-1.10],0.1453666554947358
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40391,110,0.90 [0.66-1.22],0.4876024023037379
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42542,94,1.00 [0.73-1.37],0.9980205807360566
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43433,446,1.13 [1.00-1.28],0.0513220819449066
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41046,765,0.99 [0.88-1.10],0.7957823128319146
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40393,112,0.81 [0.58-1.13],0.2232336511079686
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43828,139,0.93 [0.71-1.22],0.5795613231494918
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41991,302,1.08 [0.92-1.27],0.344110649794848
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43622,327,1.04 [0.89-1.22],0.6281904371683169
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,43086,99,0.93 [0.68-1.29],0.6764964979532361
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40389,108,1.06 [0.81-1.39],0.6727375706171448
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,43009,2728,0.96 [0.90-1.02],0.1649353518415618
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41112,831,0.99 [0.89-1.10],0.8799629055860538
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40400,119,0.84 [0.61-1.15],0.2669511424432211
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43823,528,0.91 [0.79-1.05],0.2081135107616767
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,43107,120,1.16 [0.92-1.47],0.1968046626225541
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43730,435,0.94 [0.81-1.10],0.4296392094193799
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43888,529,0.86 [0.74-1.00],0.0476010702737535
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40494,213,0.85 [0.68-1.08],0.1832988690343597
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40732,451,1.02 [0.89-1.17],0.7883474071585225
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43870,511,0.86 [0.74-1.00],0.0457007917357993
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40665,384,0.94 [0.80-1.11],0.4675312305505761
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43920,231,0.86 [0.68-1.07],0.1730956886734964
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37709,184,1.06 [0.86-1.30],0.5739379093597397
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40020,9555,1.01 [0.98-1.04],0.4158143015675644
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37626,7161,1.02 [0.98-1.05],0.3940804853023995
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37655,130,0.95 [0.72-1.25],0.6989442609814887
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38156,255,0.88 [0.72-1.09],0.2390340142391445
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38204,303,0.96 [0.80-1.14],0.6367681294815529
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43549,157,0.96 [0.75-1.22],0.7286767747917637
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",38071,170,0.90 [0.70-1.15],0.4024929313743484
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32396,1931,1.04 [0.98-1.11],0.2212575524007901
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43729,323,0.78 [0.64-0.96],0.0182950190703645
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38628,727,0.94 [0.84-1.06],0.3175986314478397
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37158,12325,0.99 [0.96-1.01],0.278916391930679
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40597,197,0.98 [0.79-1.21],0.8258314040803303
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37785,260,0.94 [0.77-1.14],0.5369108122610551
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38509,984,1.00 [0.91-1.10],0.9621970049486436
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42366,4465,0.97 [0.93-1.01],0.1735185877310779
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38000,475,0.93 [0.80-1.08],0.3453652030847255
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37907,382,1.00 [0.86-1.16],0.9719713789630602
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37765,240,0.96 [0.79-1.17],0.6725904849002313
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42831,119,0.90 [0.66-1.21],0.4750096978838209
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33308,2843,1.02 [0.96-1.07],0.5761449001457404
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31450,985,1.08 [0.99-1.18],0.0741291645470857
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43839,969,1.11 [1.02-1.21],0.0200616709603968
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30594,129,1.03 [0.80-1.32],0.8278671300653098
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31037,572,1.10 [0.99-1.23],0.0767604538989347
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38040,515,1.03 [0.91-1.17],0.6406699018364084
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31544,1079,0.94 [0.86-1.04],0.2163068421769998
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37991,90,0.93 [0.67-1.30],0.6858013268811167
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38959,1058,0.96 [0.88-1.06],0.4560823911132766
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38408,507,0.93 [0.81-1.07],0.3267105628227844
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31469,1004,0.95 [0.86-1.05],0.2981997946108181
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37656,131,1.08 [0.85-1.38],0.53344620712383
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37625,100,0.81 [0.57-1.16],0.2485735766187061
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40521,121,1.26 [1.02-1.56],0.0341212285279564
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43315,2915,1.01 [0.96-1.07],0.7349019122019893
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42315,1915,0.95 [0.89-1.02],0.1952866211159465
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43731,771,1.01 [0.91-1.12],0.8812180028374329
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34701,4236,1.00 [0.96-1.05],0.8900949022121969
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30571,106,0.94 [0.69-1.27],0.6824463348692604
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37680,155,1.17 [0.96-1.43],0.123926872129898
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30553,88,1.03 [0.76-1.40],0.8385779435849738
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30684,219,1.06 [0.88-1.27],0.5615659997077246
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40815,415,1.09 [0.95-1.24],0.2112585944883952
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,41033,633,1.06 [0.94-1.18],0.342951904025012
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43921,167,1.25 [1.05-1.49],0.0140887122125566
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40936,3035,0.96 [0.91-1.02],0.1643263223131538
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37694,169,1.10 [0.89-1.35],0.3720212360953933
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30705,240,0.96 [0.79-1.17],0.7061696654174823
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,39123,1222,0.96 [0.88-1.05],0.3941015739396073
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,34119,3654,1.02 [0.97-1.07],0.5283258362985889
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42870,158,1.00 [0.79-1.26],0.9754154956823182
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43942,130,0.70 [0.50-0.98],0.0399243085583183
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37663,138,1.09 [0.86-1.37],0.48517527390457
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39618,2093,1.02 [0.96-1.09],0.4916823922721638
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37676,151,1.02 [0.81-1.29],0.8631391882485475
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33218,2753,1.02 [0.97-1.08],0.4908905633664191
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40597,197,1.13 [0.94-1.36],0.1854479935882521
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37612,87,0.95 [0.68-1.33],0.7647140912256309
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38167,266,1.12 [0.95-1.32],0.1713145649708437
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38436,911,1.03 [0.93-1.13],0.5557909606133072
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43328,616,0.95 [0.83-1.07],0.3889745123645531
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38861,960,0.94 [0.85-1.05],0.2707290099800062
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43751,750,1.00 [0.89-1.11],0.951817429965962
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43936,87,1.13 [0.85-1.49],0.3966929843837184
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37848,323,1.10 [0.95-1.28],0.1992677227265952
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34808,1269,1.03 [0.95-1.12],0.411676772865659
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38495,970,1.00 [0.91-1.10],0.982196605059684
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37920,395,0.94 [0.80-1.10],0.4457405670343499
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30562,97,1.11 [0.85-1.45],0.4553134278243577
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34669,4204,1.03 [0.98-1.08],0.2057401335612198
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31563,1098,1.04 [0.96-1.13],0.3598461952776318
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,43104,392,0.87 [0.73-1.03],0.1009195946256245
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43861,107,1.34 [1.09-1.64],0.0046919785660685
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40323,85,0.81 [0.55-1.20],0.2974472366162858
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30598,133,0.70 [0.50-0.97],0.033421489591358
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,38074,173,0.88 [0.69-1.14],0.333801622558406
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31246,781,1.03 [0.93-1.14],0.6244040967476927
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38052,527,1.01 [0.89-1.15],0.8284196796953881
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38330,429,1.00 [0.87-1.16],0.9716154310981052
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38210,309,0.94 [0.79-1.12],0.4929074595499425
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34402,103,1.07 [0.82-1.41],0.6066252207727519
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43943,94,1.17 [0.91-1.52],0.2209060055162963
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38523,998,1.03 [0.94-1.12],0.584382827434694
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42878,166,1.17 [0.97-1.42],0.1004041108205713
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41900,4375,1.00 [0.96-1.05],0.9947555920194128
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37751,226,0.99 [0.81-1.20],0.8875125290843869
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38789,888,0.93 [0.84-1.04],0.2052239735910881
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41530,391,1.10 [0.96-1.26],0.1710285028341474
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38235,334,0.97 [0.82-1.14],0.6996668538399061
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40495,2594,0.98 [0.93-1.04],0.5680142465685083
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39600,1699,0.95 [0.88-1.03],0.2179043448451708
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37612,87,0.82 [0.56-1.19],0.3018238873920805
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42962,250,1.07 [0.90-1.27],0.4745614226750229
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37804,279,0.96 [0.80-1.16],0.6865321883926032
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37659,134,0.93 [0.71-1.22],0.6062550141241008
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30559,94,1.00 [0.74-1.36],0.9748283799542862
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,42390,2549,1.00 [0.95-1.06],0.8934820509578019
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17773,87,1.00 [0.74-1.36],0.9966599377821128
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23166,98,1.02 [0.77-1.35],0.8959778239688148
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43438,538,0.88 [0.77-1.02],0.0932492958923332
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,43042,142,1.06 [0.84-1.35],0.6038633236077022
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,42125,2284,1.00 [0.94-1.06],0.916505666370552
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43631,106,0.90 [0.66-1.24],0.5345168900550287
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43599,493,0.98 [0.86-1.13],0.8034525626375277
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38816,389,1.04 [0.89-1.20],0.6305763241202356
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Dialysis,39952,111,1.15 [0.90-1.46],0.263683513281324
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19134,2794,1.02 [0.96-1.08],0.5101083651891182
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23352,284,1.04 [0.89-1.23],0.6015864124034884
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17837,151,1.06 [0.85-1.32],0.6137175713292597
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18023,337,0.98 [0.84-1.15],0.8413320862148366
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18557,871,1.05 [0.95-1.15],0.3397419746845116
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36740,8979,1.01 [0.98-1.04],0.5232476292706106
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43653,128,1.17 [0.94-1.46],0.1623652469168878
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16515,175,1.12 [0.91-1.38],0.2988575515161337
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39796,469,0.99 [0.86-1.14],0.8845430920694968
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18537,2197,1.02 [0.95-1.09],0.5761715389764234
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23293,347,1.27 [1.13-1.43],9.073531301926824e-05
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16535,195,0.89 [0.70-1.14],0.3631714312274633
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23362,108,1.04 [0.80-1.34],0.792092840646022
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17949,263,1.02 [0.86-1.21],0.8041516930436138
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38555,128,1.03 [0.80-1.34],0.7969169479776428
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19800,2114,1.02 [0.96-1.08],0.5661669411487651
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16436,96,0.98 [0.71-1.35],0.8890859614074743
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17804,118,1.05 [0.81-1.35],0.7247212990795713
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43957,108,1.12 [0.87-1.45],0.3755246460554328
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43957,113,1.27 [1.02-1.57],0.0288199851884839
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42202,3775,1.00 [0.95-1.05],0.9998424527703612
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39642,1215,1.06 [0.97-1.15],0.1877430782544588
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23169,101,1.05 [0.80-1.39],0.7133112631058169
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43863,757,1.00 [0.90-1.12],0.9885122486060154
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16600,260,1.14 [0.97-1.35],0.1198510850530209
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16574,234,0.93 [0.75-1.15],0.50712014801451
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16535,195,1.04 [0.84-1.29],0.6955854832422729
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43909,117,1.04 [0.80-1.36],0.7764055290097235
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41320,2893,0.99 [0.94-1.05],0.8500609261136974
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23126,180,1.29 [1.10-1.52],0.0016179569267794
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17818,132,0.87 [0.66-1.17],0.3587972309882735
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18020,334,0.89 [0.74-1.06],0.1867076598721245
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17789,103,1.25 [0.99-1.57],0.056551785058227
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17868,182,1.03 [0.83-1.27],0.795036989109052
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39873,546,1.01 [0.89-1.15],0.8725574995593028
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43354,248,0.97 [0.80-1.18],0.7513081734045628
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17946,260,1.05 [0.88-1.25],0.5702383322567137
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17777,91,0.51 [0.33-0.79],0.0026320840016307
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18235,549,1.02 [0.90-1.15],0.8047147472622709
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17823,137,1.03 [0.80-1.32],0.8419774566053415
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18192,506,1.03 [0.91-1.17],0.6264266612013598
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43611,86,0.86 [0.60-1.25],0.4306149074022757
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16562,222,1.05 [0.86-1.28],0.6310836537559521
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43611,4284,0.98 [0.93-1.02],0.3417340835530971
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39523,196,0.93 [0.74-1.17],0.5285206465464429
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40036,195,1.09 [0.89-1.32],0.397423194559025
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42994,94,1.00 [0.73-1.36],0.9761150985113364
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38806,379,1.04 [0.89-1.21],0.6283443640483835
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43571,671,0.95 [0.84-1.07],0.4026401252654854
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17805,119,0.90 [0.67-1.20],0.4616775928715797
